Lucira Health to Participate in Bank of America 2022 Healthcare Conference
04 mai 2022 07h00 HE
|
Lucira Health Inc.
EMERYVILLE, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of...
Lucira Health to Announce First Quarter 2022 Financial Results
28 avr. 2022 07h00 HE
|
Lucira Health Inc.
EMERYVILLE, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of...
Lucira Health Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 avr. 2022 18h21 HE
|
Lucira Health Inc.
EMERYVILLE, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and...
Lucira Health Announces Fourth Quarter and Full Year 2021 Results and Reaffirms 2022 Financial Outlook
10 mars 2022 16h01 HE
|
Lucira Health Inc.
EMERYVILLE, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) (“Lucira Health,” “Lucira” or the “Company”), a medical technology company focused on the development and...
Lucira Health to Announce Fourth Quarter 2021 Financial Results
28 févr. 2022 17h00 HE
|
Lucira Health Inc.
EMERYVILLE, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a medical technology company focused on the development and commercialization...
Lucira Health Secures Debt Facility of Up to $80 Million from Hercules Capital and Silicon Valley Bank
08 févr. 2022 07h00 HE
|
Lucira Health Inc.
EMERYVILLE, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization...
Lucira™ Check-It PCR-Quality, At-Home Molecular COVID-19 Test Now Available in the Optum Store
11 janv. 2022 07h00 HE
|
Lucira Health Inc.
Lucira's COVID-19 test is the only EUA authorized rapid at-home self-test that delivers PCR accuracy and early detectability in a single-use test kit with results in 30 minutes Availability in the...
Lucira Health Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2021 and Provides Business Update
10 janv. 2022 07h00 HE
|
Lucira Health Inc.
EMERYVILLE, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative...
Lucira Health and Co-Defend/Co-Protect Announce Expanded Partnership for 2022
29 déc. 2021 07h00 HE
|
Lucira Health Inc.
Lucira is the only EUA authorized at-home self-test kit that delivers PCR-quality accuracy and early detectability in a single-use test kit with results in 30 minutesCo-Defend and Co-Protect are...
Lucira Health Announces Expanded Partnership with Switch Health to Increase Canadians' Access to At-Home Molecular COVID-19 Tests
22 déc. 2021 07h00 HE
|
Lucira Health Inc.
Lucira's tests are the only available at-home self-test kits that deliver PCR-quality accuracy and early detectability in a single-use test kit with results in 30 minutesCurrent surge of COVID-19...